<DOC>
	<DOC>NCT02417610</DOC>
	<brief_summary>The purpose of the study is to assess the validity of the polynucleotide within the intra articular treatment of osteoarthritis of the knee, comparing it with that of hyaluronic acid, the most commonly used.</brief_summary>
	<brief_title>Comparative Assessment of Viscosupplementation With Polynucleotides and Hyaluronic Acid</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Hyaluronic Acid</mesh_term>
	<criteria>Age between 50 and 75 years Patients informed consent Knee OA (Osteoarthritis) (ACR classification) with a Kellgren Laurence from 1 to 4 Knee pain from arisen at least 2 months BMI lower than 40 Pregnancy or lactation Severe systemic disorders History of drug abuse or alcoholism Hypersensibility to Hyaluronic acid or Polynucleotide No previous intra articular infiltration (from 3 months) No steroidal or anticoagulant systemic therapy from one month Knee articular deformity Patients affected by rheumatoid arthritis or other inflammatory articular pathologies and hematological disorders Focal skin lesion in the anatomical site of injections</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Polynucleotide</keyword>
	<keyword>Hyaluronic acid</keyword>
	<keyword>Intra articular injection</keyword>
</DOC>